Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients
Tadashi Sofue,1 Masashi Inui,2 Taiga Hara,1 Yoko Nishijima,1 Kumiko Moriwaki,1 Yushi Hayashida,3 Nobufumi Ueda,3 Akira Nishiyama,4 Yoshiyuki Kakehi,3 Masakazu Kohno1 1Division of Nephrology and Dialysis, Department of Cardiorenal and Cerebrovascular Medicine, Kagawa University, Kagawa, 2Department o...
Saved in:
Main Authors: | Sofue T (Author), Inui M (Author), Hara T (Author), Nishijima Y (Author), Moriwaki K (Author), Hayashida Y (Author), Ueda N (Author), Nishiyama A (Author), Kakehi Y (Author), Kohno M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
by: Tetsu Akimoto, et al.
Published: (2014) -
Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
by: Tetsu Akimoto, et al.
Published: (2014) -
Febuxostat in the management of hyperuricemia and chronic gout: a review
by: Miao Hu, et al.
Published: (2008) -
Febuxostat-induced agranulocytosis in a pediatric hematopoietic stem cell transplant recipient: Case Report and literature review
by: Debora Curci, et al.
Published: (2024) -
Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
by: Sollip Kim, et al.
Published: (2017)